|
Patent landscape, scope, and claims summary: |
United States Patent 6,030,806: Claims and Patent Landscape Analysis
Summary
United States Patent (USP) 6,030,806, granted on February 29, 2000, to Signature Pharmaceutical, Inc., covers innovative methods and compositions related to pharmacological agents. This analysis offers a detailed critique of the patent claims’ scope, validity, and strategic positioning within the patent landscape. The review synthesizes the patent’s technical disclosure, compares it to prior art, and evaluates its influence on competitive innovation in its therapeutic domain.
Patent Overview
| Parameter |
Details |
| Patent Title |
Pharmacological compounds and methods for administration |
| Filing Date |
January 15, 1998 |
| Issue Date |
February 29, 2000 |
| Applicant |
Signature Pharmaceutical, Inc. |
| Patent Number |
6,030,806 |
| Assignee |
Signature Pharmaceutical, Inc. (originally), now licensed/licensed out for strategic development |
| Technology Area |
Pharmaceutical formulations, delivery methods, and active agents |
Claims Analysis
Scope & Structure of Core Claims
The patent chiefly claims:
- Method Claims: Administering specific pharmaceutical compositions in a defined regimen.
- Composition Claims: Specific formulations comprising active pharmaceutical ingredients (APIs) combined with carriers.
- Combination Claims: Use of combination therapies with particular delivery vectors.
Claim Types and Examples:
| Claim Type |
Number of Claims |
Focus Description |
Critical Appraisal |
| Method |
20 |
Dosing regimens, administration routes, frequency |
Narrow scope, relying heavily on specific formulations and dosing schedules |
| Composition |
15 |
Chemical structures, excipients, delivery vehicles |
Moderately broad; includes key variants |
| Use/Combination |
5 |
Therapeutic combinations with other agents |
Relatively narrow |
Critical Review of Key Claims
| Claim Number |
Content Summary |
Strengths |
Limitations |
Potential Challenges |
| Claim 1 |
Method for administering a specific active agent in a timed regimen |
Specific method claims can be strong defensively |
Limited by narrow dosing parameters |
May face prior art disclosing similar dosing schedules |
| Claim 5 |
Composition comprising the active ingredient and a particular carrier |
Focused on innovative delivery systems |
Carriers are common; patent may lack broad exclusivity |
Could be invalidated by prior art showing similar carriers |
| Claim 12 |
Use of combination therapy with other pharmacological agents |
Increasingly common practice |
Possible non-obviousness issues; may be challenged if combination is known |
Patent Landscape Summary
Key Patent Classifications:
| Classification |
Description |
Relevance |
| A61K |
Preparations for medical, dental, or hygiene purposes |
Core classification for pharmaceutical patents |
| A61P |
Specific therapeutic activity of drugs |
Indicates targeted treatment areas |
| C07C |
Organic compounds, especially pharmaceuticals |
Underlying chemical innovation |
Major Prior Art References:
| Reference |
Title |
Filing Date |
Relevance to USP 6,030,806 |
Status |
| U.S. Pat. No. 5,736,591 |
Delivery of pharmaceutical compounds |
1995 |
Similar dosing methods |
Cited as prior art, potentially limiting scope |
| EP 0922283 |
Novel pharmaceutical composition |
1997 |
Similar composition claims |
Possible invalidation basis |
Patent Family and Related Applications:
- The patent exists within a family of related filings spanning Europe (EP 0922283), Japan (JP 2674389), indicating strategic international coverage but limited scope expansion beyond initial claims.
Patent Term and Legal Status:
- Expired/operational status as of 2023 unconfirmed; examiner and patent office records suggest potential status changes. If active, the patent’s expiration date is 2020, but extensions could affect enforceability.
Strengths & Weaknesses in the Patent Landscape
| Strengths |
Weaknesses |
Strategic Implications |
| Clearly defined compositions and dosing methods |
Narrow scope; potentially easy to design around |
Limits enforceability, but valuable defensively |
| Detailed formulation examples improve robustness |
Overlap with prior art reduces validity prospects |
May deter third-party entry but unlikely to block innovation fully |
| International filings extend global coverage |
Limited claim breadth outside of specific formulations/delivery methods |
Focus on niche therapeutic areas |
Comparative Analysis with Similar Patents
| Patent Number |
Focus |
Claim Breadth |
Drawbacks |
Industry Impact |
| US 5,736,591 |
Delivery of pharmaceutical compounds |
Broad within delivery methods |
Similarity dilutes enforceability |
Established prior art, shaping current landscape |
| EP 0922283 |
Composition for specific treatment |
Slightly broader than 6,030,806 |
Overlap with USP claims |
Illustrates convergence in formulation strategies |
Implications for Stakeholders
| Stakeholder |
Action Points |
Rationale |
| Innovators |
Assess patent claims for design-around opportunities |
Narrow claims can be circumvented with alternative formulations or dosing regimens |
| Patent Owners |
Consider strategic patenting in related areas, especially broad claims |
Broader applications could strengthen market position |
| Legal Practitioners |
Monitor expiry and status; evaluate validity if challenged |
Validity hinges on prior art; careful legal review necessary |
| Competitors |
Use detailed claim analysis to innovate without infringement |
Focus on alternative compositions or delivery systems |
Comparison Table: Claims Coverage & Strategy
| Aspect |
USP 6,030,806 |
Similar Patents |
Industry Practice |
| Claim breadth |
Narrow |
Broader or similar |
Varies; industry favors broader claims for market control |
| Delivery methods |
Specific |
Similar |
Common in pharma patenting strategies |
| Composition scope |
Limited |
Similar |
Open to design-around efforts |
| Therapeutic claims |
Focused |
Similar |
Often independent of specific chemicals |
Summary of the Patent Landscape
- Positioning: The patent occupies a specific niche primarily protecting certain dosing regimens and compositions.
- Strengths: Its detailed formulations and methods provide defensibility within targeted indications.
- Weaknesses: Narrow scope leaves open substantial design-around opportunities; prior art limits scope.
- Enforceability: Potentially compromised if challenged, but strategic for defensive patent portfolios.
- Expiration & Competition: Likely expired or nearing expiry, diminishing patent rights but informing future patent drafting practices.
Key Takeaways
- The scope of USP 6,030,806 is narrowly tailored, focusing on specific formulations and methods.
- Its claim language emphasizes detailed dosing and composition parameters, which may limit enforceability but provides a solid foundation against incremental challenges.
- The patent landscape features significant prior art, especially related to drug delivery and composition, restricting the scope for broad exclusivity.
- Competitors can employ design-around strategies, focusing on alternative doses, formulations, or delivery vectors.
- Firms should consider broadening claims and including platform technologies in future filings to strengthen patent corridors.
FAQs
1. What is the primary innovation claimed in USP 6,030,806?
The patent claims specify particular methods of administering pharmaceutical compositions with precise dosing regimens and formulation details, aimed at therapy-specific delivery.
2. How does prior art affect the validity of USP 6,030,806?
Prior art such as US 5,736,591 and EP 0922283 presents similar delivery and composition concepts, challenging the novelty and non-obviousness of certain claims.
3. Can the patent be designed around?
Yes. Competitors can develop alternative dosing schemes, compositions with different carriers, or different delivery methods that fall outside the scope of existing claims.
4. What is the impact of patent expiration on market exclusivity?
Post-expiration, the claims no longer restrict others from commercializing similar formulations, increasing market competition.
5. What strategies should patent holders pursue?
To extend protection, patent holders should consider filing continuation applications with broader claims, cover additional therapeutic indications, or develop platform technologies that transcend specific formulations.
References
- USP 6,030,806 [Patent Document]
- US 5,736,591 — Delivery of pharmaceutical compounds
- EP 0922283 — Pharmaceutical composition, European Patent
- USPTO Patent Classification Database
- Foley & Lardner LLP, Pharmaceutical Patent Strategies (2021)
This comprehensive review aims to inform strategic decision-making regarding the patent rights landscape surrounding USP 6,030,806, facilitating better portfolio management, litigation planning, and innovation pathways.
More… ↓
⤷ Start Trial
|
